Increasing levels of circulating Th17 cells and interleukin-17 in rheumatoid arthritis patients with an inadequate response to anti-TNF-α therapy
Arthritis Research & Therapy2011Vol. 13(4), pp. R126–R126
Citations Over TimeTop 10% of 2011 papers
Abstract
The beneficial effect of anti-TNF-α therapy might involve a decrease in Th17-related cytokines in responders, whereas rising levels of circulating Th17-cells and IL-17 were observed in patients with an inadequate response to anti-TNF-α therapy.
Related Papers
- → IL-17A, IL-22, and IL-23 as Markers of Psoriasis Activity(2015)52 cited
- → Out of the shadow of interleukin-17A: the role of interleukin-17F and other interleukin-17 family cytokines in spondyloarthritis(2021)12 cited
- → Interleukin (IL)-35 Suppresses IL-6 and IL-8 Production in IL-17A-Stimulated Human Periodontal Ligament Cells(2018)19 cited
- [National or international rheumatology? On the problems of rheumatism and rheumatology].(1966)